Earnings Call · Q2 FY2022·2022-08-09

Q2 22EPS +100.00%*·Rev n/aQ1 22EPS +28.57%·Rev n/aQ4 21EPS 0.00%·Rev n/aQ3 21EPS -2.86%·Rev n/a⚠ consensus missing

Dare Bioscience, Inc. DARE

Sabrina Johnson — Executive

John Fair — Executive

Lisa Walters-Hoffert — Chief Financial Officer

−2.4%1d on move date−2.0% vs SPY3d−5.6%5d+0.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more DARE calls or request research access.

More DARE calls Browse calls Request research access